Document Detail

The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis: a long-term (>4 years) pivotal study.
MedLine Citation:
PMID:  19092614     Owner:  NLM     Status:  MEDLINE    
STUDY DESIGN: Randomized controlled trial comparing OP-1 (rhBMP-7) with iliac crest autograft in patients with symptomatic degenerative spondylolisthesis and spinal stenosis treated with decompression and uninstrumented posterolateral arthrodesis. OBJECTIVE: To determine the safety and the clinical and radiographic efficacy of OP-1 (rhBMP-7) Putty as compared with an iliac crest bone autograft control in uninstrumented, single-level posterolateral spinal arthrodesis. SUMMARY OF BACKGROUND DATA: Preclinical and preliminary clinical data have demonstrated successful fusion and clinical outcomes with the use of OP-1 Putty in posterolateral spinal arthrodesis. No prior randomized controlled trial with adequate study power has been performed. METHODS: A total of 335 patients were randomized in 2:1 fashion to receive either OP-1 Putty or autograft in the setting of an uninstrumented posterolateral arthrodesis performed for degenerative spondylolisthesis and symptomatic spinal stenosis. Patients were observed serially with radiographs, clinical examinations, and appropriate clinical indicators, including ODI, Short-Form 36, and visual analog scale scores. Serum samples were examined at regular intervals to assess the presence of antibodies to OP-1. The primary end point, Overall Success, was analyzed at 24 months. The study was extended to include additional imaging data and long-term clinical follow-up at 36+ months. At the 36+ month time point, CT scans were obtained in addition to plain radiographs to evaluate the presence and location of new bone formation. Modified Overall Success, including improvements in ODI, absence of retreatment, neurologic success, absence of device-related serious adverse events, angulation and translation success, and new bone formation by CT scan (at 36+ months), was then calculated using the 24-month primary clinical endpoints, updated retreatment data, and CT imaging and radiographic end points. RESULTS: OP-1 Putty was demonstrated to be statistically equivalent to autograft with respect to the primary end point of modified overall success. The use of OP-1 Putty when compared to autograft was associated with statistically lower intraoperative blood loss and shorter operative times. Although patients in the OP-1 Putty group demonstrated an early propensity for formation of anti-OP-1 antibodies, this resolved completely in all patients with no clinical sequelae. CONCLUSION: OP-1 Putty is a safe and effective alternative to autograft in the setting of uninstrumented posterolateral spinal arthrodesis performed for degenerative spondylolisthesis and symptomatic spinal stenosis.
Alexander R Vaccaro; James P Lawrence; Tushar Patel; Lee D Katz; D Greg Anderson; Jeffrey S Fischgrund; Julie Krop; Michael G Fehlings; David Wong
Related Documents :
19927104 - Increased hemoglobin levels in patients with early onset scoliosis: prevalence and effe...
19829254 - Increasing lumbar lordosis of adult spinal deformity patients via intraoperative prone ...
16741454 - Clinical results of surgery for thoracic myelopathy caused by ossification of the poste...
1607974 - Scoliosis in pediatric chiari malformations without myelodysplasia.
699644 - Diagnostic value of fiberoptic bronchoscopy in metastatic pulmonary tumors.
16271274 - Diagnostic and therapeutic laser conization for cervical intraepithelial neoplasia.
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Spine     Volume:  33     ISSN:  1528-1159     ISO Abbreviation:  Spine     Publication Date:  2008 Dec 
Date Detail:
Created Date:  2008-12-18     Completed Date:  2009-07-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7610646     Medline TA:  Spine (Phila Pa 1976)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2850-62     Citation Subset:  IM    
Department of Orthopaedic Surgery, Thomas Jefferson University and The Rothman Institute, Philadelphia, PA 19107, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arthrodesis / methods
Bone Morphogenetic Proteins / administration & dosage*,  adverse effects*
Bone Transplantation / adverse effects,  methods*
Follow-Up Studies
Ilium / transplantation*
Lumbar Vertebrae / radiography,  surgery*
Middle Aged
Spinal Fusion / adverse effects,  methods*
Spondylolisthesis / radiography,  surgery
Transplantation, Autologous / adverse effects,  methods
Reg. No./Substance:
0/Bone Morphogenetic Proteins; 0/osteogenic protein 1 putty, recombinant human

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  RhBMP-2 Versus Iliac Crest Bone Graft for Lumbar Spine Fusion: A Randomized, Controlled Trial in Pat...
Next Document:  Effects of clotrimazole on experimental spinal cord ischemia/reperfusion injury in rats.